ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,178Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 315

$471K Total Retail Price of All Prescriptions

Rank: 78 out of 315

454 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

6% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 5,753 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LISINOPRIL 279 230 1 3
SIMVASTATIN 274 243 2 1
AMLODIPINE BESYLATE 262 209 3 2
ATORVASTATIN CALCIUM 232 210 4 5
LOSARTAN POTASSIUM 205 198 5 4
OMEPRAZOLE 198 154 6 9
TRAMADOL HCL 170 62 7 59
ATENOLOL 151 124 8 11
TAMSULOSIN HCL 139 108 9 21
GABAPENTIN 139 89 9 37
LEVOTHYROXINE SODIUM 136 102 11 6
METFORMIN HCL 136 118 11 7
FUROSEMIDE 123 95 13 15
CELEBREX 104 96 14 34
ALLOPURINOL 103 103 15 14
LOVASTATIN 101 98 16 8
ALENDRONATE SODIUM 101 95 16 12
HYDROCHLOROTHIAZIDE 98 74 18 16
METOPROLOL TARTRATE 92 68 19 18
ZOLPIDEM TARTRATE 90 73 20 29
CARVEDILOL 82 78 21 22
PANTOPRAZOLE SODIUM 81 61 22 35
AZITHROMYCIN 77 62 23 39
METOPROLOL SUCCINATE 72 68 24 13
FELODIPINE ER 72 63 24 23
LOSARTAN-HYDROCHLOROTHIAZIDE 62 45 26 17
DIOVAN 62 53 26 27
HYDROCODONE-ACETAMINOPHEN 61 35 S3 28 19
GLIPIZIDE 60 50 29 30
OXYCODONE HCL 59 25 S2 30 57
JANUVIA 59 59 30 31
ADVAIR DISKUS 57 48 32 46
PRAVASTATIN SODIUM 55 55 33 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 31, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.